Skip to main content

Binge eating and biochemical markers of appetite in new users of the contraceptive depot medroxyprogesterone acetate

Abstract

Purpose

Weight gain has been cited by women as one of the main reasons for discontinuation of the contraceptive depot medroxyprogesterone acetate (DMPA). This study aimed to evaluate binge eating and the biochemical markers of appetite in new DMPA users.

Methods

In this prospective non randomized study with adult healthy women, twenty-eight users of DMPA and twenty-five users of a copper intrauterine device (IUD) were paired for age (±1 year) and body mass index (BMI) (±1 kg/m2). We evaluated binge eating using the Binge Eating Scale (BES), the serum levels of neuropeptide Y, leptin and adiponectin, and the BMI at baseline and after 12 months in both groups. For statistical analysis was used ANOVA for to compare the means of the repeated measurements.

Results

Mean age was 29.6 and 28.6 years and BMI was 23.9 and 24.5 kg/m2 for the DMPA and IUD groups, respectively. After 12 months, the frequency of the scores of binge eating remained low in both groups. There were no significant differences between the groups at 12 months with respect to BMI, levels of NPY, leptin, adiponectin, and BES scores.

Conclusions

Healthy adult women did not present with central stimulation of appetite or binge eating disorder in their first year after starting use of DMPA. This study reinforces the use of the contraceptive DPMA and the need for guidance related to living a healthy lifestyle for women who attribute the increase of body weight to the use of the method.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Fraser IS, Weisberg E (1981) A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. Med J Aust 1(1 Suppl):3–19

    CAS  PubMed  Google Scholar 

  2. 2.

    Kaunitz AM (1996) Long-acting contraceptive options. Int J Fertil Menopausal Stud 41(2):69–76

    CAS  PubMed  Google Scholar 

  3. 3.

    Bakry S, Merhi ZO, Scalise TJ, Mahmoud MS, Fadiel A, Naftolin F (2008) Depot-medroxyprogesterone acetate: an update. Arch Gynecol Obstet 278(1):1–12

    Article  PubMed  Google Scholar 

  4. 4.

    Westhoff C (2003) Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety. Contraception 68(2):75–87

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Wanyonyi SZ, Stones WR, Sequeira E (2011) Health-related quality of life changes among users of depot medroxyprogesterone acetate for contraception. Contraception 84(5):e17–e22

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Amatayakul K, Sivasomboon B, Thanangkul O (1980) A study of the mechanism of weight gain in medroxyprogesterone acetate users. Contraception 22(6):605–6226

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Clark MK, Dillon JS, Sowers M, Nichols S (2005) Weight, fat mass and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception. Int J Obes 29(10):1252–1258

    CAS  Article  Google Scholar 

  8. 8.

    Le YC, Rahman M, Berenson AB (2009) Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users. Obstet Gynecol 114(2):279–284

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM (1995) Metabolic parameter, bleeding, and weight in US women using progestin only contraceptives. Contraception 51(3):149–153

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Taneepanichskul S, Reinprayoon D, Khaosaad P (1999) Effects of DMPA on weight and blood pressure in long-term acceptors. Contraception 59(5):301–303

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Pelkman CL, Chow M, Heinbach RA, Rolls BJ (2001) Short-term effects of a progestational contraceptive drug on food intake, resting energy expenditure, and body weight in young women. Am J Clin Nutr 73(1):19–26

    CAS  PubMed  Google Scholar 

  12. 12.

    Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF (2013) Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception 88(4):503–508

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Buffenstein R, Poppitt SD, McDevitt RM, Prentice AM (1995) Food intake and the menstrual cycle: a retrospective analysis, with implications for appetite research. Physiol Behav 58(6):1067–1077

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Hirschberg AL (2012) Sex hormones, appetite and eating behavior in women. Maturitas 71(3):248–256

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Beck B (2006) Neuropeptide Y in normal eating and in genetic and dietary-induced obesity. Philos Trans R Soc Lond B Biol Sci. http://rstb.royalsocietypublishing.org/content/royptb/361/1471/1159.full.pdf. Accessed 18 May 2016

  16. 16.

    Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296(5858):659–660

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Kokot F, Ficek R (1999) Effects of neuropeptide Y on appetite. Miner Electrolyte Metab 25(4–6):303–305

    CAS  PubMed  Google Scholar 

  18. 18.

    Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB, Elmquist JK (1999) Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23(4):775–786

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Weigle DS, Breen PA, Matthys CC, Callahan HS, Meeuws KE, Burden VR, Purnell JQ (2005) A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr 82(1):41–48

    CAS  PubMed  Google Scholar 

  20. 20.

    Schinner S, Scherbaum WA, Bornstein SR, Barthel A (2005) Molecular mechanisms of insulin resistance. Diabet Med 22(6):674–682

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Cursino K, Sider M, Pavin EJ, Dos Santos PN, Bahamondes L, Zantut-Wittmann DE, Fernandes A (2016) Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during 1 year of use. Eur J Contracept Reprod Health Care 21(1):22–29

    Article  PubMed  Google Scholar 

  22. 22.

    Dos Santos P, Bahamondes VM, Modesto W, Bahamondes L, Fernandes A (accepted for publication in 2017). Dietary intake and body composition in new users of the injectable contraceptive depot-medroxyprogesterone acetate during the first year of use. J Reprod Med (in press)

  23. 23.

    ABEP (2009) Brazilian Association of Research Companies. The Brazilian Economic Classification Criteria. http://www.abep.org/criterioBrasil.aspx. Accessed 18 May 2016

  24. 24.

    Ford ES, Kohl HW 3rd, Mokdad AH, Ajani UA (2005) Sedentary behavior, physical activity, and the metabolic syndrome among US adults. Obes Res 13:608–614

    Article  PubMed  Google Scholar 

  25. 25.

    Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP (2011) American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43(7):1334–1359

    Article  PubMed  Google Scholar 

  26. 26.

    Gormally J, Black S, Daston S, Rardin D (1982) The assessment of binge eating severity among obese persons. Addict Behav 7(1):47–55

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Freitas S, Lopes CS, Coutinho W, Appolinario JC (2001) Translation and adaptation into of the Binge-Eating Scale. Rev Bras Psiquiatr 23(4):215–220 (Portuguese)

    Article  Google Scholar 

  28. 28.

    American Psychiatry Association (2013) Feeding and eating disorders. Diagnostic and statistical manual of mental disorders (DSM-5). http://www.dsm5.org/documents/eating%20disorders%20fact%20sheet.pdf. Accessed 18 May 2016

  29. 29.

    Berenson AB, Rahman M (2009) Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. Am J Obstet Gynecol 200(3):329.e1-8

    Article  PubMed  Google Scholar 

  30. 30.

    Bonny AE, Britto MT, Huang B, Succop P, Slap GB (2004) Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA). J Pediatr Adolesc Gynecol 17(2):109–115

    Article  PubMed  Google Scholar 

  31. 31.

    Bonny AE, Lange HL, Hade EM, Kaufman B, Reed MD, Mesiano S (2015) Serum adipocytokines and adipose weight gain: a pilot study in adolescent females initiating depot medroxyprogesterone acetate. Contraception 92(4):298–300

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

São Paulo Research Foundation (FAPESP), Grant #2011/14827-9 and CAPES (Coordination for the Improvement of Higher Education Personnel) through a Grant conceded to PNSS. The original study was funded by the Brazilian National Research Council (CNPq) and by the Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP), Secretaria de Estado da Saúde de São Paulo (SES-SP) Grant PPSUS/2009, #2009/53293-0, Brazil. The authors claim they have not a financial relationship with the organization that sponsored the research. We claim that we have had full control of all primary data and that we agree to allow the Journal to review their data if requested.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Arlete Fernandes.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest. The authors alone are responsible for the content and the writing of the paper.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Silva dos Santos, P.d., de Souza, A.L., Batista, G.A. et al. Binge eating and biochemical markers of appetite in new users of the contraceptive depot medroxyprogesterone acetate. Arch Gynecol Obstet 294, 1331–1336 (2016). https://doi.org/10.1007/s00404-016-4192-9

Download citation

Keywords

  • Depot medroxyprogesterone acetate
  • Contraception
  • NPY
  • Appetite
  • Eating disorder